PRODUCTION OF NEW DIETETIC MILK PRODUCTS FOR RISK POPULATIONS BASED ON QUALITATIVE AND QUANTITATIVE ANALYSIS OF HEALTH RISK MARKERS IN MILK CONSUMPTION

Exploring the potential reasons for controversial opinions on the significance of milk in diet it is necessary to consider both the ‘desirable’ and the ‘undesirable’ milk components and development of massive non-infectious diseases (atherosclerosis, hypertension, infarction, cerebrovascular insult, allergies, autoimmune diseases, schizophrenia, autism and carcinoma). We will explore the concentration of: uric acid, purines and pyrimidines, ß-casein A1, lactose, as well as the exogenous agents (macro and micro elements, heavy metals, 16 most common pesticides, radioactive components, derivatives of plastic mass decomposition, such as diethylphthalate – DEHP, Diisononyl phthalate – DINP and bisphenol – A). During the project, we propose developing of continuous production of ‘depurinised milk’, composite dairy products for risk groups on the basis of potentially useful metabolic, antioxidant and membrane-protective effects, to define the genotype and establish the most common quantitative phenotype of ß-casein A1 and A2 in cow’s milk which would enable the production of ‘A2’ milk. The presence of heavy metals, pesticides or plastic mass derivatives could point to the necessity of producing ‘purified’ dairy products in risk areas using modern technologies. Enzyme analyses of human milk aim at pointing to the advantage of breastfeeding over artificial nutrition and forming the ‘human milk banks’.